Abstract

Simple SummaryThe cheetah (genus Acinonyx), which is considered vulnerable by the IUCN Red List, suffers quite frequently from chronic gastrointestinal (GI) diseases, often associated with Helicobacter spp., with a significant mortality, especially in captive animals. The study of the fecal proteome aims to investigate possible new markers of disease that could be useful in diagnosing and/or monitoring, when performed in feces, gastrointestinal disorders. Considering the invasiveness of some diagnostic investigations (e.g., GI endoscopy) in general and the difficulties of carrying out even simple blood sampling in animals such as the cheetah, the possibility of deriving clinical-diagnostic information from fecal samples is extremely interesting. Herein, a fecal proteomic evaluation from healthy and diseased cheetahs suffering from GI disorders is performed.Fecal proteomics allows for the identification of proteins and peptides present in stools and is useful in finding possible new biomarkers for diagnosing and/or monitoring gastrointestinal (GI) disorders. In the present study, we investigated the fecal proteome in healthy and diseased cheetahs (Acinonyx jubatus). Captive individuals of this species frequently show gastrointestinal disorders characterized by recurrent episodes of diarrhea, rare episodes of vomiting and weight loss, associated with Helicobacter spp. infection. Fecal proteomic evaluation has been performed by two-dimensional electrophoresis followed by liquid chromatography-tandem mass spectrometry. In healthy cheetahs, the results showed the presence of the following proteins: collagen alpha-1 (II) chain, transthyretin, IgG Fc-binding protein, titin, dystonin, isopentenyl-diphosphate Delta-isomerase 1, sodium/potassium-transporting ATPase subunit alpha-1 and protein disulfide-isomerase A6. The presence of albumin isoforms was found only in diseased cheetahs. The present paper reports the study of the fecal proteome in the cheetah, evidences some differences between healthy and diseased patients and confirms, once again, the potential of fecal proteomics for the study of the GI environment, with promising developments regarding the identification of new diagnostic/monitoring markers.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.